TIMP-1 and -2 have been shown to participate in pulmonary diseases characterized by alterations of the alveolar structure or abnormal remodeling responses such as emphysema, interstitial fibrosis, acute respiratory distress syndrome, and lung cancer [44]. Here, TIMP1 is linked to pulmonary emphysema.